
51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
🔥 6 minutes ago
🇺🇸 United States – Remote
💵 $80 - $100 / hour
⏳ Contract/Temporary
🟠 Senior
🔴 Lead
🖥 Software Engineer
👻 Ghost score 10%
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2019
🧬 Biotechnology
💊 Pharmaceuticals
🔬 Science
💰 $85M Series B on 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. The company is pioneering CAR T-cell therapies, leveraging the transformational power of T cells to potentially provide sustained, treatment-free remission for autoimmune conditions. Kyverna's lead CAR T-cell therapy candidate, KYV-101, is advancing through clinical trials targeting various autoimmune diseases, including multiple sclerosis, myasthenia gravis, systemic sclerosis, and lupus nephritis. Their pipeline features innovative chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats aimed at B cell-driven autoimmune diseases.
• Act as the lead programmer for assigned clinical trials and work closely with the study statistician, clinical data management, and other study-team functions. • Lead the strategic design, creation, mapping, and validation of SDTM and ADaM datasets, ensuring data traceability. • Perform statistical analysis and program and validate Tables, Listings, and Figures using SAS for Clinical Study Reports, Development Safety Update Reports, ad-hoc requests, and publications. • Review and ensure the quality of CDISC packages, including aCRF, SDTM/ADaM datasets, Pinnacle 21 reports, cSDRG/ADRG, and define XML for eCTD submissions. • Perform other duties as assigned.
• Bachelor’s, Master’s in Statistics, Biostatistics, Computer Science, Mathematics, or a highly related Scientific discipline. • 8+ years of statistical programming experience within a bio/pharma company, or clinical research organization (CRO). • Advanced proficiency in SAS, including complicated data steps, Macro language, and commonly used analysis procedures such as PROC FREQ, PROC REPORT, PROC SQL, and PROC MIXED. • Comprehensive understanding of CDISC standards and experience generating regulatory package artifacts like define.xml and Reviewer's Guides (cSDRG, ADRG). • Strong communication, analytical, and problem-solving skills, with excellent time management and the ability to independently manage multiple high-priority projects in a fast-paced environment. • Excellent interpersonal skills and the ability to collaborate effectively as part of a cross-functional team. • Demonstrated ability to work independently, communicate proactively, and deliver results effectively in a remote work environment.
Apply Now🔥 5 hours ago
SAP Developer leading SAP Analytics Cloud and Datasphere solutions. Modernizing planning, reporting, integrations, and financial analytics for enterprise operations.
🔥 19 hours ago
Senior Statistical Programmer leading SAS and CDISC programming for oncology clinical trials at ClinChoice, a global clinical-development CRO. Managing analyses, regulatory deliverables, validation, and mentoring programmers.
🕒 Yesterday
MuleSoft architect developing secure APIs and enterprise integrations for government technology systems. Overseeing platform architecture, deployment, governance, and integration delivery.
🕒 2 days ago
51 - 200
Nuclear experts red-teaming Mercor’s frontier AI models for misuse and safeguards risks. Writing adversarial prompts, evaluating responses, and documenting technically grounded reference answers.
🇺🇸 United States – Remote
💵 $65 - $75 / day
🔥 Funding within the last year
💰 $350M Series C - Mercor on 2025-10
⏳ Contract/Temporary
🟡 Mid-level
🟠 Senior
🖥 Software Engineer
🕒 2 days ago
Project Developer contractor developing energy-efficiency and infrastructure retrofits for existing data centers. Conducting field assessments, engineering analysis, cost estimates, and client proposals.